Tua says he's playing the game the way he always has. That means taking some risks, whether we like it or not, including ...

VICTORIA, BC, Nov. 14, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinic ...

The poster child for new automotive technology is a dynamic, adaptable system that allows for continuous improvements to the ...

As Oman prepares to celebrate its 54th National Day, people and businesses across the governorates are decking up their ...

Q3 2024 Earnings Call Transcript November 14, 2024 Affimed N.V. beats earnings expectations. Reported EPS is $-1.03, ...

Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024Iqirvo approved for use in the U.S. in June 2024, in the E.U. in September 202 ...

Topline data from Phase 2 CM24 pancreatic cancer trial expected by the end of 2024New CM24 biomarkers data presented during the third quarter of ...

As Nov. 8 marks Indigenous Veterans Day, a display in the main entrance of the school, created by First Nations Metis and ...

HBsAg levels less than 1000 IU/mL achieved functional cure in Cohort A1 of the IM-PROVE I Phase 2a clinical trial . Overall, in Cohort A1, 25% of ...

SeaStar Medical Holding Corporation (Nasdaq: ICU) ("SeaStar Medical" or the "Company"), a commercial-stage medical device company developing proprietary solutions ...

Revenue: Revenue was $4.7 million for the three months ended September 30, 2024, compared to $6.9 million for the same period in 2023. The decrease was primarily due to lower partnering revenues as a ...

The historic action, which was voted for in a ballot by the National Pharmacy Association (NPA), saw 99% of pharmacy owners ...